Yiwei Li mainly focuses on Cancer research, Cancer, Cancer stem cell, Cell growth and Internal medicine. His studies deal with areas such as Epithelial–mesenchymal transition, Metastasis, Genistein, Pancreatic cancer and Cancer cell as well as Cancer research. In his study, Cell cycle is inextricably linked to Carcinogenesis, which falls within the broad field of Cancer cell.
His research on Cancer often connects related topics like Pharmacology. His Cancer stem cell research includes elements of microRNA, CD44 and Cellular differentiation. The study incorporates disciplines such as Apoptosis, Notch 1, Signal transduction, Notch signaling pathway and Prostate cancer in addition to Cell growth.
Yiwei Li mostly deals with Cancer research, Cancer, Cell growth, Cancer stem cell and Internal medicine. He has included themes like Pancreatic cancer, Cancer cell, Apoptosis, microRNA and Metastasis in his Cancer research study. His Cancer study integrates concerns from other disciplines, such as Genistein, Immunology, Isoflavones, Pharmacology and Programmed cell death.
His studies deal with areas such as Notch 1, Signal transduction, Cell biology, Cell cycle and Prostate cancer as well as Cell growth. His work carried out in the field of Cancer stem cell brings together such families of science as Epithelial–mesenchymal transition, CD44 and Cellular differentiation. As part of one scientific family, Yiwei Li deals mainly with the area of Internal medicine, narrowing it down to issues related to the Endocrinology, and often Diindolylmethane.
His primary scientific interests are in Cancer research, microRNA, Cancer, Cancer stem cell and Pancreatic cancer. His study in Cancer research is interdisciplinary in nature, drawing from both CD44, Cell growth, Cancer cell, Signal transduction and Metastasis. His microRNA research is multidisciplinary, incorporating perspectives in Bioinformatics, Carcinogenesis, Cell biology, Hedgehog and Epigenetics.
His Cancer research includes themes of Inflammation, Oxidative stress, Nuclear export signal and Pharmacology. His Cancer stem cell research is multidisciplinary, relying on both Epithelial–mesenchymal transition, Tumor progression, Prostate cancer and Oncology. His Pancreatic cancer research is included under the broader classification of Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
Yiwei Li;Timothy G. VandenBoom;Dejuan Kong;Zhiwei Wang.
Cancer Research (2009)
Multi-targeted therapy of cancer by genistein
Sanjeev Banerjee;Yiwei Li;Zhiwei Wang;Fazlul H. Sarkar.
Cancer Letters (2008)
Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
Zhiwei Wang;Yiwei Li;Dejuan Kong;Sanjeev Banerjee.
Cancer Research (2009)
miR-146a suppresses invasion of pancreatic cancer cells
Yiwei Li;Timothy G. VandenBoom;Zhiwei Wang;Dejuan Kong.
Cancer Research (2010)
Inactivation of Nuclear Factor κB by Soy Isoflavone Genistein Contributes to Increased Apoptosis Induced by Chemotherapeutic Agents in Human Cancer Cells
Yiwei Li;Fakhara Ahmed;Shadan Ali;Philip A. Philip.
Cancer Research (2005)
Soy Isoflavones and Cancer Prevention
Fazlul H. Sarkar;Yiwei Li.
Cancer Investigation (2003)
Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells.
Dejuan Kong;Sanjeev Banerjee;Aamir Ahmad;Yiwei Li.
PLOS ONE (2010)
Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Sreenivasa R Chinni;Yiwei Li;Sunil Upadhyay;Prathima K Koppolu.
Down-regulation of Notch-1 inhibits invasion by inactivation of nuclear factor-κB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells
Zhiwei Wang;Sanjeev Banerjee;Yiwei Li;K.M. Wahidur Rahman.
Cancer Research (2006)
Inhibition of Nuclear Factor κB Activation in PC3 Cells by Genistein Is Mediated via Akt Signaling Pathway
Yiwei Li;Fazlul H. Sarkar.
Clinical Cancer Research (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: